Return to study ST002125 main page

Samples for study ST002125

Species: Mus musculus (Factor headings shown in green)
mb_sample_id Subject name Sample name Source_Name[gating] Treatment Batch Note Sample_Data:RAW_FILE_NAME
SA204320-BM_supernatant_5FU_1Bone marrow supernatant 5 FU 2 weeks 1c Unlabeled AAs were used for total AA (FigS2.D)bms-fu-1.cdf
SA204321-BM_supernatant_5FU_2Bone marrow supernatant 5 FU 2 weeks 1c Unlabeled AAs were used for total AA (FigS2.D)bms-fu-2.cdf
SA204322-BM_supernatant_5FU_3Bone marrow supernatant 5 FU 2 weeks 1c Unlabeled AAs were used for total AA (FigS2.D)bms-fu-3.cdf
SA204323-BM_supernatant_Ctrl_1Bone marrow supernatant HSC Basal 1c Unlabeled AAs were used for total AA (FigS2.D)bms-ct-1.cdf
SA204324-BM_supernatant_Ctrl_2Bone marrow supernatant HSC Basal 1c Unlabeled AAs were used for total AA (FigS2.D)bms-ct-2.cdf
SA204325-BM_supernatant_Ctrl_3Bone marrow supernatant HSC Basal 1c Unlabeled AAs were used for total AA (FigS2.D)bms-ct-3.cdf
SA204326-HSC_5FU_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J).hsc-fu-1.cdf
SA204328-HSC_5FU_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J).hsc-fu-2.cdf
SA204327-HSC_5FU_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J).hsc-fu-3.cdf
SA204331-HSC_5FU_0h_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-fu-0h-1.cdf
SA204330-HSC_5FU_0h_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-fu-0h-2.cdf
SA204329-HSC_5FU_0h_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-fu-0h-3.cdf
SA204333-HSC_5FU_12h_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-fu-12h-1.cdf
SA204334-HSC_5FU_12h_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-fu-12h-2.cdf
SA204332-HSC_5FU_12h_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-fu-12h-3.cdf
SA204335-HSC_5FU_6h_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-fu-6h-1.cdf
SA204337-HSC_5FU_6h_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-fu-6h-2.cdf
SA204336-HSC_5FU_6h_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-fu-6h-3.cdf
SA204340-HSC_Cultured_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig2.B); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C) and TCA substrate levels (Fig2.K).hsc-cultured-1.cdf
SA204339-HSC_Cultured_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig2.B); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C) and TCA substrate levels (Fig2.K).hsc-cultured-2.cdf
SA204338-HSC_Cultured_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig2.B); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C) and TCA substrate levels (Fig2.K).hsc-cultured-3.cdf
SA204342-HSC_Cultured_0h_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-cultured-0h-1.cdf
SA204343-HSC_Cultured_0h_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-cultured-0h-2.cdf
SA204344-HSC_Cultured_0h_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-cultured-0h-3.cdf
SA204341-HSC_Cultured_6h_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-cultured-6h-1.cdf
SA204347-HSC_Cultured_12h_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-cultured-12h-1.cdf
SA204346-HSC_Cultured_12h_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-cultured-12h-2.cdf
SA204345-HSC_Cultured_12h_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-cultured-12h-3.cdf
SA204348-HSC_Cultured_6h_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-cultured-6h-2.cdf
SA204349-HSC_Cultured_6h_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) Ex vivo culture 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig2.D).hsc-cultured-6h-3.cdf
SA204355-HSC_Ctrl_0h_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D).hsc-ct-0h-1.cdf
SA204353-HSC_Ctrl_0h_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D).hsc-ct-0h-2.cdf
SA204354-HSC_Ctrl_0h_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D).hsc-ct-0h-3.cdf
SA204358-HSC_Ctrl_12h_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D).hsc-ct-12h-1.cdf
SA204357-HSC_Ctrl_12h_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D).hsc-ct-12h-2.cdf
SA204356-HSC_Ctrl_12h_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D).hsc-ct-12h-3.cdf
SA204359-HSC_Ctrl_6h_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D).hsc-ct-6h-1.cdf
SA204360-HSC_Ctrl_6h_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D).hsc-ct-6h-2.cdf
SA204361-HSC_Ctrl_6h_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h 1b [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig1.C, Fig2.D).hsc-ct-6h-3.cdf
SA204351-HSC_Ctrl_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal or Ctrl, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J).hsc-ct-1.cdf
SA204352-HSC_Ctrl_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal or Ctrl, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J).hsc-ct-2.cdf
SA204350-HSC_Ctrl_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal or Ctrl, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J).hsc-ct-3.cdf
  logo